Table 2.
Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|
OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Age | 1.18 (1.04;1.35) | 0.013 | 1.37 (1.05;1.79) | 0.021 |
Female | 0.97 (0.28;3.36) | 0.964 | 3.01 (0.31;29.20) | 0.342 |
Charlson Comorbidity Index | 1.31 (0.96;1.80) | 0.092 | 1.39 (0.78;2.48) | 0.268 |
Diabetes | 0.56 (0.12;2.68) | 0,466 | 0.60 (0.06;5.91) | 0.662 |
Chronic respiratory disease | 1.83 (0.45;7.43) | 0.401 | 0.27 (0.02;3.91) | 0.334 |
Chronic cardiac disease | 3.26 (1.04;10.24) | 0.043 | 6.48 (0.56;74.69) | 0.134 |
Immunosuppression | 0.94 (0.19;4.65) | 0.944 | 1.62 (0.16;16.40) | 0.683 |
ADL score | 0.69 (0.50;0.95) | 0.027 | 0.36 (0.17;0.75) | 0.006 |
Number of drugs | 1.16 (0.96;1.40) | 0.128 | 1.15 (0.83;1.61) | 0.405 |
Nosocomial infection | 0.58 (0.15;2.22) | 0.426 | 2.17 (0.18;26.76) | 0.545 |
Antiviral < 48 h | 0.33 (0.09;1.27) | 0.107 | 0.04 (0.002;0.78) | 0.034 |
Antibiotic prescription | 3.67 (0.97;13.94) | 0.057 | 0.64 (0.07;6.28) | 0.704 |
SOFA score | 1.83 (1.27;2.64) | 0.001 | 2.30 (1.07;4.94) | 0.034 |
Lymphopenia | 2.17 (0.45;10.45) | 0.336 | 0.42 (0.04;4.03) | 0.453 |
OR, Odds Ratios; ADL, Activities of Daily Living; SOFA, Sequential Organ Failure Assessment